When considering human settlements on the moon, Mars and further afield, much attention is given to the travel times, food and radiation risk. We'll undoubtedly face a harsh environment in deep space and some thinkers have ...
Current gene therapies to treat sickle cell disease are complex, time-consuming, and are sometimes linked to serious side effects like infertility or blood cancer. To address these challenges, Johns Hopkins researchers have ...
Ginseng's role in traditional medicine is underscored by its complex genetic structure due to its allotetraploid nature. A recent study delves into this complexity, revealing key evolutionary insights into its subgenomes ...
Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has published a study in Nature that unlocks genome editing of bacteria in the gut.
Genome editing stands as one of the most transformative scientific breakthroughs of our time. It allows us to dive into the very code of life and make precise modifications. Imagine being able to rewrite the genetic instructions ...
Genome editing has become a widely adopted technology to modify DNA in cells, allowing scientists to study diseases in the lab and develop therapies that repair disease-causing mutations. However, with current approaches, ...
On March 27, 2024, a study published in the journal Nature announced that the sugarcane genome had at last been cracked. This was a remarkable achievement because of the complexity of the sugarcane's genome. That of rice, ...
Apicomplexan parasites are a common cause of disease, infecting hundreds of millions of people each year. They are responsible for spreading malaria; cryptosporidiosis—a severe childhood diarrheal disease; and toxoplasmosis—a ...
With the goal of reducing the time and cost it takes to bring an improved crop to the marketplace to improve agriculture sustainability, research conducted in the laboratory of Keith Slotkin, Ph.D., and his colleagues in ...
In a leap forward for genetic engineering, a team of researchers from the Arc Institute has discovered the bridge recombinase mechanism, a precise and powerful tool to recombine and rearrange DNA in a programmable way.
